Search results
Amgen's (AMGN) Blincyto Gets FDA Nod for Consolidation Treatment
Zacks· 15 hours agoFree Report) announced that the FDA has granted approval to its leukemia drug, Blincyto, for consolidation treatment, regardless of measurable residual disease (MRD) status ...
Joe Grogan: Access to new Alzheimer’s treatments bogged down by Medicare policy
Chicago Tribune· 10 hours agoAlzheimer’s is a progressive, fatal disease that boggled scientists for a century. Now, at last, we...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 3 days agoThe FDA approved AstraZeneca’s AZN type-II diabetes (T2D) medicine, Farxiga, for pediatric...
Two Is Better Than One in the Alzheimer’s Market
The Wall Street Journal· 9 hours agoLast week, a panel of independent advisers to the FDA unanimously voted in support of Eli Lilly donanemab, a competitor in the same class of drugs that...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks· 15 hours agoFree Report) submitted an application to the FDA, seeking to amend its Emergency Use Authorization (EUA) and update its protein-based COVID-19 vaccine for the upcoming fall ...
Amgen's (AMGN) Blincyto Gets FDA Nod for Consolidation Treatment
Zacks via Yahoo Finance· 6 hours agoAmgen's (AMGN) Blincyto is now approved for the treatment of adult and pediatric patients one month...
SCOTUS Avoids Merits Ruling That Would Disrupt FDA Drug Reviews
Bloomberg Law· 6 hours agoThe court’s ruling means mifepristone remains legal nationwide, and permits doctors to continue to prescribe it via telehealth. Perhaps more importantly, by deciding the case on procedural grounds ...
Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
Zacks via Yahoo Finance· 3 days agoThe FDA approves Bristol Myers' (BMY) cancer drug Augtyro for the treatment of adult and pediatric...
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 4 days ago"FDA approves AstraZeneca’s Farxiga for paediatric T2D patients" was originally created and...
The FDA Should Reject MDMA Therapy—but Not for the Reasons You Think
Slate via Yahoo News· 4 days agoIf the FDA approves Lykos’ application in August, it would be the first time in the agency’s history...